A Standardized Approach to Fertility Preservation Discussions
Pediatric oncology and bone marrow transplant patients are experiencing increased long-term survival, which has created a need to consider...
An Analysis of Advanced Care Planning and End-of-Life Outcomes in Patients Who Received Allo-HCT
A retrospective study presented during the 2021 ASCO Annual Meeting assessed how advanced care planning (ACP) affected end-of-life (EOL)...
Outcomes in Ph-Like ALL Versus Ph+ and Ph- ALL
A study presented during the 2021 ASCO Annual Meeting compared outcomes in patients with Philadelphia-like acute lymphoblastic leukemia (Ph-like...
Prognostic Understanding Affects Hospitalization, Hospice Use
For older patients with advanced cancer, poor prognostic understanding of the curability of their disease may affect their hospitalizations...
Are Patients Satisfied with Telehealth?
Satisfaction with telehealth (TH) is high among patients with cancer, according to a study presented during the 2021 ASCO...
Electronic App to Monitor Symptoms Following HSCT
The lives of patients who undergo hematopoietic stem cell transplantation (HSCT) change in several ways. A study presented during...
CD34 Stem Cell Boost Following Allo-HCT May Improve Outcomes
A systemic review and meta-analysis aimed to assess the outcomes with stem cell boost (SCB) for poor graft function...
Nurse-Collected PRO Initiative May Increase Improve QoL in Older Patients Receiving Treatment
The use of patient-reported outcomes (PROs) in clinical practice significantly improved quality of life (QoL) among older patients receiving...
Growth Rate and Site of Pulmonary Metastasis Lung Relapse, OS in B-STS
A study presented during the 2021 ASCO Annual Meeting found that the growth rate and site of pulmonary metastasis...
Hematology and Oncology News
Curated Journal Abstracts
Today's Top 5
5. Genomic Analysis for Guiding Treatment of Rare Cancer
Huge effort in the field of #PrecisionMedicine :
— Philippe Aftimos, MD (@aftimosp) June 11, 2021
🔹Molecular profiling 🧬of rare cancers
🔹Cross-institutional molecular tumor board👩💻👨💻(management recommendations, diagnostic reevaluation, genetic counseling, & experimental treatment)
🔹Treatment access💊and efficacy evaluation https://t.co/S66YtALeCu
4. Population Diversity in Cancer Trials
Our paper on population diversity in cancer trials just out @IntJCanc
— emre yekeduz,MD (@yekeduz_emre) June 14, 2021
Honored to be included in this study w/ my great mentors @DrYukselUrun gungorutkan @DrChoueiri @curijoey @darioT_ @VriesElisabeth @ShuchiGulati @chadinabhan @VincentWenxinXu @oncology_bg @Chrislabaki1
3. July 1 Issue of Cancer Is Out Now
At #EHA2021 good discussion on tailoring treatment in MM between @MyMKaiser and Dr. Stefania Oliva moderated by @Mohty_EBMT . 60% vs 40% for lag of evidence on tailoring, ie. predicting, #MultipleMyeloma treatment for now. @MDSAlliance @lyle_foreningen pic.twitter.com/BW9QPQgR6s
— MDS and You - MDS og Dig (@mds_niels) June 14, 2021
2. Tailoring MM Treatment
At #EHA2021 good discussion on tailoring treatment in MM between @MyMKaiser and Dr. Stefania Oliva moderated by @Mohty_EBMT . 60% vs 40% for lag of evidence on tailoring, ie. predicting, #MultipleMyeloma treatment for now. @MDSAlliance @lyle_foreningen pic.twitter.com/BW9QPQgR6s
— MDS and You - MDS og Dig (@mds_niels) June 14, 2021
1. NSCLC Surgical Outcomes
Efficacy, safety, and surgical outcomes were summarized by @DoctorJSpicer, scientist in the RI-MUHC’s Cancer Research Program #CRP https://t.co/RmeUvC81b7
— RI-MUHC (@RIMUHC1) June 14, 2021